Evidence map›Paper›PMID 32469862›Full record

ArticlePLoS genetics2020

Saccharomyces cerevisiae Mus81-Mms4 prevents accelerated senescence in telomerase-deficient cells.

Erin K Schwartz, Shih-Hsun Hung, Damon Meyer, Aurèle Piazza, Kevin Yan, Becky Xu Hua Fu, Wolf-Dietrich Heyer

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Erin K SchwartzDepartment of Microbiology and Molecular Genetics, University of California, Davis, Davis, California, United States of America.ORCID 0000-0003-4923-4513
Shih-Hsun HungDepartment of Microbiology and Molecular Genetics, University of California, Davis, Davis, California, United States of America.ORCID 0000-0002-1958-817X
Damon MeyerDepartment of Microbiology and Molecular Genetics, University of California, Davis, Davis, California, United States of America.
Aurèle PiazzaDepartment of Microbiology and Molecular Genetics, University of California, Davis, Davis, California, United States of America.ORCID 0000-0002-7722-0955
Kevin YanDepartment of Microbiology and Molecular Genetics, University of California, Davis, Davis, California, United States of America.
Becky Xu Hua FuDepartment of Microbiology and Molecular Genetics, University of California, Davis, Davis, California, United States of America.ORCID 0000-0002-3095-2956
Wolf-Dietrich HeyerDepartment of Microbiology and Molecular Genetics, University of California, Davis, Davis, California, United States of America.ORCID 0000-0002-7774-1953
University of California, Davis · USUniversité Claude Bernard Lyon 1 · FR

Funding

RECOMBINATIONAL MECHANISMS OF DNA REPAIR IN EUKARYOTESR01GM058015 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI HEYER, WOLF-DIETRICH · 2000 to 2025
$8.8M
Regulation of Recombinational DNA RepairR01CA092276 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI HEYER, WOLF-DIETRICH · 2001 to 2020
$5.2M
Hormones, DNA Repair, BRCA1/2 and Ovarian Cancer Preven*R03CA092776 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MODUGNO, FRANCESMARY · 2002 to 2003
$149k
Howard Hughes Medical InstituteNCI NIH HHS R01 CA092276NCI NIH HHS R03 CA092776NIGMS NIH HHS R01 GM058015
6 · The paper itself

Abstract

Alternative lengthening of telomeres (ALT) in human cells is a conserved process that is often activated in telomerase-deficient human cancers. This process exploits components of the recombination machinery to extend telomere ends, thus allowing for increased proliferative potential. Human MUS81 (Mus81 in Saccharomyces cerevisiae) is the catalytic subunit of structure-selective endonucleases involved in recombination and has been implicated in the ALT mechanism. However, it is unclear whether MUS81 activity at the telomere is specific to ALT cells or if it is required for more general aspects of telomere stability. In this study, we use S. cerevisiae to evaluate the contribution of the conserved Mus81-Mms4 endonuclease in telomerase-deficient yeast cells that maintain their telomeres by mechanisms akin to human ALT. Similar to human cells, we find that yeast Mus81 readily localizes to telomeres and its activity is important for viability after initial loss of telomerase. Interestingly, our analysis reveals that yeast Mus81 is not required for the survival of cells undergoing recombination-mediated telomere lengthening, i.e. for ALT itself. Rather we infer from genetic analysis that Mus81-Mms4 facilitates telomere replication during times of telomere instability. Furthermore, combining mus81 mutants with mutants of a yeast telomere replication factor, Rrm3, reveals that the two proteins function in parallel to promote normal growth during times of telomere stress. Combined with previous reports, our data can be interpreted in a consistent model in which both yeast and human MUS81-dependent nucleases participate in the recovery of stalled replication forks within telomeric DNA. Furthermore, this process becomes crucial under conditions of additional replication stress, such as telomere replication in telomerase-deficient cells.

Indexed as

DNA-Binding ProteinsDNA ReplicationEndonucleasesFlap EndonucleasesMicrobial ViabilityRecombination, GeneticSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTelomeraseTelomereTelomere HomeostasisDNA-Binding ProteinsEndonucleasesFlap EndonucleasesMMS4 protein, S cerevisiaeMUS81 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsTelomerase

Identifiers

PMID32469862
PMCPMC7286520
OpenAlexW3031100207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.